Dr. Namratha Kamath

Dr. Namratha Kamath has extensive experience in clinical trial management and monitoring, currently serving as the Central and Risk-Based Monitoring Manager at Accelsiors CRO from July 2022 to April 2024. Dr. Kamath has developed risk-based monitoring processes and led related activities globally, ensuring compliance with SOPs and good clinical practices. Prior roles include significant positions at PPD, where responsibilities spanned from Senior Central Monitoring Analyst to Central Monitoring Analyst, contributing to the assessment of clinical trial data integrity and risk identification. Experience also includes work at Novartis as a Clinical Scientific Expert, focusing on data review and quality assurance, and at QuintilesIMS in various data review capacities. Dr. Kamath began the career at Indegene, managing a team in clinical trial analysis. Academic qualifications include a Bachelor of Dentistry from Rajiv Gandhi University of Health Sciences.